119 related articles for article (PubMed ID: 35534452)
1. Erratum: Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
Zhou P; Zheng ZH; Wan T; Wu J; Liao CW; Sun XJ
J Gastric Cancer; 2022 Apr; 22(2):156. PubMed ID: 35534452
[TBL] [Abstract][Full Text] [Related]
2. Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
Zhou P; Zheng ZH; Wan T; Wu J; Liao CW; Sun XJ
J Gastric Cancer; 2021 Dec; 21(4):439-456. PubMed ID: 35079445
[TBL] [Abstract][Full Text] [Related]
3. Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway through TSC1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo.
Chen M; Lu J; Wei W; Lv Y; Zhang X; Yao Y; Wang L; Ling T; Zou X
Onco Targets Ther; 2018; 11():6705-6722. PubMed ID: 30349304
[TBL] [Abstract][Full Text] [Related]
4. miR-145 Inhibits Th9 Cell Differentiation by Suppressing Activation of the PI3K/Akt/mTOR/p70S6K/HIF-1α Pathway in Malignant Ascites from Liver Cancer.
Huang YY; Jiang HX; Shi QY; Qiu X; Wei X; Zhang XL; Qin SY
Onco Targets Ther; 2020; 13():3789-3800. PubMed ID: 32440147
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
[TBL] [Abstract][Full Text] [Related]
7. 12-Deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1α in MCF-7 cells by blocking the PI3K/Akt/mTOR signaling pathway.
Yang Y; Cong H; Han C; Yue L; Dong H; Liu J
Oncol Rep; 2015 Oct; 34(4):1755-60. PubMed ID: 26239613
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1α expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cells.
Zhang J; Guo H; Zhu JS; Yang YC; Chen WX; Chen NW
Oncol Lett; 2014 May; 7(5):1401-1408. PubMed ID: 24765145
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression.
Zhang J; Xu J; Dong Y; Huang B
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29899167
[TBL] [Abstract][Full Text] [Related]
10. Rhapontigenin inhibits TGF-β-mediated epithelial‑mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation.
Yeh YH; Wang SW; Yeh YC; Hsiao HF; Li TK
Oncol Rep; 2016 May; 35(5):2887-95. PubMed ID: 26986649
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
[TBL] [Abstract][Full Text] [Related]
12. High-Mobility Group Box 1 (HMGB1) Promotes Angiogenesis and Tumor Migration by Regulating Hypoxia-Inducible Factor 1 (HIF-1α) Expression via the Phosphatidylinositol 3-Kinase (PI3K)/AKT Signaling Pathway in Breast Cancer Cells.
He H; Wang X; Chen J; Sun L; Sun H; Xie K
Med Sci Monit; 2019 Apr; 25():2352-2360. PubMed ID: 30930461
[TBL] [Abstract][Full Text] [Related]
13. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor 1 α protects mesenchymal stem cells against oxygen-glucose deprivation-induced injury via autophagy induction and PI3K/AKT/mTOR signaling pathway.
Lv B; Hua T; Li F; Han J; Fang J; Xu L; Sun C; Zhang Z; Feng Z; Jiang X
Am J Transl Res; 2017; 9(5):2492-2499. PubMed ID: 28559999
[TBL] [Abstract][Full Text] [Related]
15. HMGB1/PI3K/Akt/mTOR Signaling Participates in the Pathological Process of Acute Lung Injury by Regulating the Maturation and Function of Dendritic Cells.
Li R; Zou X; Huang H; Yu Y; Zhang H; Liu P; Pan S; Ouyang Y; Shang Y
Front Immunol; 2020; 11():1104. PubMed ID: 32636835
[No Abstract] [Full Text] [Related]
16. Cryptotanshinone inhibits the growth and invasion of colon cancer by suppressing inflammation and tumor angiogenesis through modulating MMP/TIMP system, PI3K/Akt/mTOR signaling and HIF-1α nuclear translocation.
Zhang L; Chen C; Duanmu J; Wu Y; Tao J; Yang A; Yin X; Xiong B; Gu J; Li C; Liu Z
Int Immunopharmacol; 2018 Dec; 65():429-437. PubMed ID: 30388517
[TBL] [Abstract][Full Text] [Related]
17. Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells.
Zhang E; Feng X; Liu F; Zhang P; Liang J; Tang X
PLoS One; 2014; 9(7):e103440. PubMed ID: 25058399
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39.
Nan Y; Guo H; Guo L; Wang L; Ren B; Yu K; Huang Q; Zhong Y
Hum Gene Ther Clin Dev; 2018 Sep; 29(3):156-166. PubMed ID: 30180756
[TBL] [Abstract][Full Text] [Related]
19. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
Petrella BL; Brinckerhoff CE
Cancer Biol Ther; 2009 Jul; 8(14):1389-401. PubMed ID: 19483472
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LncHIFCAR promotes osteoarthritis development via positively regulating HIF-1α and activating the PI3K/AKT/mTOR pathway.
Sun J; Song X; Su L; Cao S
Int J Clin Exp Pathol; 2018; 11(6):3000-3009. PubMed ID: 31938425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
